Literature DB >> 11026867

Dose equivalents of tumour repopulation during radiotherapy: the potential for confusion.

R G Dale1, B Jones, J A Sinclair.   

Abstract

When employing linear quadratic equations to calculate compensation for changes in overall treatment time, a potential confusion exists regarding use of the parameter commonly described as the dose equivalent of tumour repopulation. The more correct term for this factor is the biologically effective dose equivalent of tumour repopulation. The distinction between the two concepts is discussed and the potential errors arising from their confusion are illustrated by means of an example.

Entities:  

Mesh:

Year:  2000        PMID: 11026867     DOI: 10.1259/bjr.73.872.11026867

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  4 in total

1.  Effect of hyperoxygenation on tissue pO2 and its effect on radiotherapeutic efficacy of orthotopic F98 gliomas.

Authors:  Nadeem Khan; Sriram Mupparaju; Shahryar K Hekmatyar; Huagang Hou; Jean P Lariviere; Eugene Demidenko; David J Gladstone; Risto A Kauppinen; Harold M Swartz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-08-31       Impact factor: 7.038

2.  Evaluation of Biological Effective Dose in Gamma Knife Staged Stereotactic Radiosurgery for Large Brain Metastases.

Authors:  Taoran Cui; Joseph Weiner; Shabbar Danish; Anupama Chundury; Nisha Ohri; Ning Yue; Xiao Wang; Ke Nie
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

3.  Assessment of the changes in 9L and C6 glioma pO2 by EPR oximetry as a prognostic indicator of differential response to radiotherapy.

Authors:  Huagang Hou; Sriram P Mupparaju; Jean P Lariviere; Sassan Hodge; Jiang Gui; Harold M Swartz; Nadeem Khan
Journal:  Radiat Res       Date:  2013-02-07       Impact factor: 2.841

Review 4.  [Practical update of total dose compensation in case of temporary interruption of external radiotherapy in the COVID-19 pandemic context].

Authors:  D Azria; C Hennequin; P Giraud
Journal:  Cancer Radiother       Date:  2020-04-10       Impact factor: 1.018

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.